DOP1A and infection: Given that linezolid is a last-resort antimicrobial agent for treating serious infections caused by Gram-positive bacteria, community-acquired optrA-positive enterococci and optrA-carrying plasmids and other origins, especially the optrA-positive E. faecalis and pAD1 + DOp1-type plasmids, should be incorporated into public health monitoring programs.